BTX ECM2001 Cell Fusion and Electroporation Instrument

Overview

The BTX ECM2001 Cell Fusion and Electroporation Instrument is a dual-mode, microprocessor-controlled electroporation system engineered for high-precision cell manipulation in developmental biology, reproductive biotechnology, and regenerative medicine. It operates on the principle of controlled electric field–induced membrane permeabilization (electroporation) and dielectrophoretic cell alignment followed by electrofusion—two distinct but synergistic biophysical processes. Unlike single-function devices, the ECM2001 integrates programmable AC pre-fusion, DC fusion pulse delivery, and post-fusion AC stabilization into a unified, time-synchronized waveform architecture. This triphasic protocol enables reproducible, high-yield somatic cell nuclear transfer (SCNT), hybridoma generation, and transgenic cell line establishment under defined physiological conditions.

Key Features

• Triphasic waveform control: Independent programming of AC pre-alignment (1–2 MHz sine or square wave), DC fusion pulse (square-wave, 1–99 V, 1–99 µs duration, 1–99 pulses), and low-voltage AC post-stabilization (≤5 V, 100 kHz–1 MHz)
• Microsecond-scale AC/DC switching: <10 µs transition time between AC alignment and DC fusion phases to minimize thermal stress and maximize membrane resealing fidelity
• Dual operational modes: Dedicated electroporation mode (high-voltage DC square pulses only) and integrated electrofusion mode (AC–DC–AC sequence)
• Programmable pulse parameters: Adjustable voltage, pulse width, number of pulses, and inter-pulse intervals with non-volatile memory for up to 20 user-defined protocols
• Compatible electrode configurations: Standard 1 mm gap cuvettes, custom fusion chambers, and miniaturized slide-based fusion devices (e.g., BTX Fusion Chamber Slides)
• Real-time impedance monitoring: Built-in circuitry detects sample conductivity changes during pulse delivery to ensure consistent energy delivery across variable cell densities and buffer conductivities

Sample Compatibility & Compliance

The ECM2001 supports a broad range of eukaryotic cell types—including murine and bovine oocytes, porcine blastomeres, human embryonic stem cells, and hybridoma precursors—when suspended in low-conductivity fusion buffers (e.g., mannitol–HEPES or sucrose–Ca²⁺ solutions). Its waveform architecture meets the biophysical requirements outlined in ISO 13485–compliant laboratory workflows for cell therapy process development. While not FDA-cleared as a medical device, the instrument is routinely employed in GLP-compliant preclinical studies supporting IND-enabling data packages per ICH S6(R1). All protocols are fully traceable and support audit-ready documentation when paired with BTX’s optional LabVIEW-based data logging module.

Software & Data Management

The ECM2001 operates via front-panel keypad interface with LED status feedback; no PC connection is required for basic operation. For advanced workflow integration, optional BTX FusionControl™ software (Windows-compatible) enables remote parameter scripting, real-time pulse visualization, and export of timestamped CSV logs containing voltage, current, and pulse timing metadata. All saved protocols include operator ID, date/time stamp, and environmental temperature (via external probe input), satisfying 21 CFR Part 11 requirements for electronic records when deployed with validated IT infrastructure and role-based access controls.

Applications

• Somatic cell nuclear transfer (SCNT): Precise fusion of enucleated oocytes with donor somatic nuclei (e.g., adult fibroblasts), followed by electrical activation—validated in landmark studies including Wilmut et al. (1997, Nature) for Dolly the sheep and Meng et al. (1997, Biol Reprod) for rhesus macaque cloning
• Hybridoma generation: Efficient fusion of antibody-producing B lymphocytes with immortalized myeloma cells under optimized AC alignment and DC pulse conditions
• Embryonic stem cell reprogramming: Delivery of transcription factor mRNAs or CRISPR ribonucleoproteins into pluripotent cells using high-efficiency electroporation mode
• Transgenic livestock production: Nuclear transfer into porcine or bovine zygotes using serum-starved donor cells, as demonstrated by PPL Therapeutics’ SCNT-derived therapeutic protein–producing pigs
• Developmental toxicity screening: Transient transfection of reporter constructs into early-stage embryos for lineage tracing and gene function analysis

FAQ

What distinguishes the ECM2001 from standard electroporators?
It uniquely combines programmable AC dielectrophoresis for cell alignment with precisely timed DC fusion pulses and post-fusion AC stabilization—enabling true electrofusion capability absent in conventional electroporation-only systems.
Can the ECM2001 be used for CRISPR/Cas9 RNP delivery?
Yes—its electroporation mode delivers high-efficiency, low-toxicity RNP transfection into hard-to-transfect primary cells and stem cells when optimized for pulse amplitude and duration.
Is the ECM2001 compatible with GMP manufacturing environments?
While the instrument itself is not GMP-certified, its repeatable waveform output, protocol traceability, and compatibility with validated fusion chambers support use in GMP-aligned process development for ATMPs (Advanced Therapy Medicinal Products).
Does BTX provide application support for nuclear transfer protocols?
Yes—BTX offers documented SOPs, peer-reviewed protocol references, and technical consultation for SCNT, hybridoma, and stem cell applications through its Life Sciences Application Support Team.
What safety certifications does the ECM2001 hold?
It complies with IEC 61010-1:2010 for laboratory electrical equipment and carries CE marking for EMC and low-voltage directive compliance. UL certification is available upon request for North American installations.